Marco Colombi

3.4k total citations · 3 hit papers
23 papers, 2.5k citations indexed

About

Marco Colombi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marco Colombi has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Marco Colombi's work include Cancer, Hypoxia, and Metabolism (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Marco Colombi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Marco Colombi collaborates with scholars based in Switzerland, Spain and United States. Marco Colombi's co-authors include Michael N. Hall, Christoph Moroni, Don Benjamin, Suzette Moes, Sravanth K. Hindupur, Markus H. Heim, Eva Dazert, Paul Jenoe, Mitsugu Shimobayashi and Yakir Guri and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marco Colombi

23 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapamycin passes the torch: a new generation of mTOR inhibitors

2011 782 citations Don Benjamin, Marco Colombi et al. Nature Reviews Drug Discovery profile →
Insulin resistance causes inflammation in adipose tissue

2018 348 citations Mitsugu Shimobayashi, Verena Albert et al. Journal of Clinical Investigation profile →
Arginine reprograms metabolism in liver cancer via RBM39

2023 145 citations Dirk Mossmann, Christoph Müller et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Colombi Switzerland	13	1.5k	613	474	371	309	23	2.5k
Bożena Samborska Canada	14	1.4k 0.9×	698 1.1×	352 0.7×	452 1.2×	236 0.8×	18	2.1k
Elena Ansó Spain	12	1.5k 1.0×	793 1.3×	255 0.5×	366 1.0×	323 1.0×	14	2.3k
Steven Zhao United States	11	1.3k 0.9×	720 1.2×	382 0.8×	379 1.0×	254 0.8×	17	2.1k
Tohru Yamamori Japan	26	1.4k 0.9×	290 0.5×	330 0.7×	640 1.7×	252 0.8×	58	2.8k
Daqian Xu China	26	1.8k 1.2×	1.2k 1.9×	509 1.1×	241 0.6×	348 1.1×	48	3.0k
Gyesoon Yoon South Korea	31	2.1k 1.4×	599 1.0×	489 1.0×	948 2.6×	413 1.3×	64	3.4k
Gerta Hoxhaj United States	18	2.7k 1.7×	878 1.4×	383 0.8×	408 1.1×	456 1.5×	24	3.7k
Geoffrey D. Girnun United States	25	2.3k 1.5×	1.2k 2.0×	326 0.7×	613 1.7×	365 1.2×	33	3.3k
Frank Weinberg United States	19	2.1k 1.4×	1.2k 1.9×	335 0.7×	228 0.6×	540 1.7×	46	3.3k

Countries citing papers authored by Marco Colombi

Since Specialization

Citations

This map shows the geographic impact of Marco Colombi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Colombi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Colombi more than expected).

Fields of papers citing papers by Marco Colombi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Colombi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Colombi. The network helps show where Marco Colombi may publish in the future.

Co-authorship network of co-authors of Marco Colombi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Colombi. A scholar is included among the top collaborators of Marco Colombi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Colombi. Marco Colombi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mossmann, Dirk, Christoph Müller, Sujin Park, et al.. (2023). Arginine reprograms metabolism in liver cancer via RBM39. Cell. 186(23). 5068–5083.e23. 145 indexed citations breakdown →

Ng, Charlotte K.Y., Eva Dazert, Mairene Coto‐Llerena, et al.. (2022). Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. Nature Communications. 13(1). 2436–2436. 88 indexed citations

Park, Sujin, Dirk Mossmann, Qian Chen, et al.. (2022). Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis. Molecular Cell. 82(22). 4246–4261.e11. 18 indexed citations

Frei, Irina C., Diana Weißenberger, Danilo Ritz, et al.. (2022). Adipose mTORC2 is essential for sensory innervation in white adipose tissue and whole-body energy homeostasis. Molecular Metabolism. 65. 101580–101580. 12 indexed citations

Dimitrakopoulos, Christos, Sravanth K. Hindupur, Marco Colombi, et al.. (2021). Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma. BMC Genomics. 22(1). 592–592. 10 indexed citations

Hindupur, Sravanth K., Marco Colombi, Stephen R. Fuhs, et al.. (2018). The protein histidine phosphatase LHPP is a tumour suppressor. Nature. 555(7698). 678–682. 169 indexed citations

Benjamin, Don, Dimitri Robay, Sravanth K. Hindupur, et al.. (2018). Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells. Cell Reports. 25(11). 3047–3058.e4. 281 indexed citations

Shimobayashi, Mitsugu, Verena Albert, Bettina Woelnerhanssen, et al.. (2018). Insulin resistance causes inflammation in adipose tissue. Journal of Clinical Investigation. 128(4). 1538–1550. 348 indexed citations breakdown →

Guri, Yakir, Marco Colombi, Eva Dazert, et al.. (2017). mTORC2 Promotes Tumorigenesis via Lipid Synthesis. Cancer Cell. 32(6). 807–823.e12. 303 indexed citations

10.

Dazert, Eva, Marco Colombi, Tujana Boldanova, et al.. (2016). Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient. Proceedings of the National Academy of Sciences. 113(5). 1381–1386. 54 indexed citations

11.

Albert, Verena, Kristoffer Svensson, Mitsugu Shimobayashi, et al.. (2016). mTORC 2 sustains thermogenesis via Akt‐induced glucose uptake and glycolysis in brown adipose tissue. EMBO Molecular Medicine. 8(3). 232–246. 112 indexed citations

12.

Benjamin, Don, Marco Colombi, Christoph Moroni, & Michael N. Hall. (2011). Rapamycin passes the torch: a new generation of mTOR inhibitors. Nature Reviews Drug Discovery. 10(11). 868–880. 782 indexed citations breakdown →

13.

Colombi, Marco, Don Benjamin, Christiane Schaefer, et al.. (2010). Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. Oncogene. 30(13). 1551–1565. 37 indexed citations

14.

Colombi, Marco, et al.. (2006). Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants. Oncogene. 25(50). 6595–6603. 3 indexed citations

15.

Schraml, Peter, Holger Moch, Marco Colombi, et al.. (1997). p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer. International Journal of Oncology. 10(4). 801–6. 6 indexed citations

16.

Colombi, Marco, et al.. (1990). The Heterotopic Effects of Insulin and Glucagon on the Acinar Activity Pattern of Phosphoenolpyruvate Carboxykinase in Male and Female Rat Liver. Biological Chemistry Hoppe-Seyler. 371(2). 1129–1136. 2 indexed citations

17.

Colombi, Marco, et al.. (1990). The effects of acetylsalicylic acid on phosphoenolpyruvate carboxykinase activity and acinar heterotopy in livers from juvenile and adult rats. Histochemistry and Cell Biology. 94(2). 149–153. 1 indexed citations

18.

Colombi, Marco, et al.. (1990). Changes in the acinar activity patterns of phosphoenolpyruvate carboxykinase in livers of male and female rats upon feeding a high protein and a high fat diet. Histochemistry and Cell Biology. 93(3). 257–62. 12 indexed citations

19.

Colombi, Marco, et al.. (1990). The development of the acinar heterotopic pattern of phosphoenolpyruvate carboxykinase activity in the newborn rat. Histochemistry and Cell Biology. 94(1). 55–9. 3 indexed citations

20.

Colombi, Marco, et al.. (1990). Enzyme activity patterns of phosphoenolpyruvate carboxykinase, pyruvate kinase, glucose-6-phosphate-dehydrogenase and malic enzyme in human liver. Histochemistry and Cell Biology. 93(4). 409–415. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact